secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001683168-24-002616
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma effects 1-for-100 reverse stock split effective April 17, 2024
--------------------------------------------------------------------------------

- 1-for-100 reverse split of common stock (SBFM) and warrants (SBFMW) effective April 17, 2024.
- Certificate of amendment filed with Colorado Secretary of State to implement the split.
- No additional details on rationale, post-split share count, or Nasdaq compliance provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824002616/0001683168-24-002616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824002616/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-002616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer